Design Therapeutics Inc. (DSGN)
4.12
0.10 (2.49%)
At close: Jan 15, 2025, 11:38 AM
Balance Sheet (Annual)
Get detailed breakdowns of the balance-sheet with total debts, total investments, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Cash & Equivalents | 21.20M | 26.50M | 298.57M | 2.38M | 77.00K |
| Short-Term Investments | 260.60M | 303.89M | 85.50M | 33.71M | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 430.00K | 459.00K | n/a | 212.00K | n/a |
| Receivables | 1.43M | 1.11M | 110.00K | 10.00K | n/a |
| Inventory | n/a | -1.11M | 1.25M | 107.00K | n/a |
| Other Current Assets | 1.35M | 8.35M | 1.26M | 132.00K | 5.00K |
| Total Current Assets | 284.58M | 335.12M | 385.44M | 36.23M | 90.00K |
| Property-Plant & Equipment | 4.63M | 5.56M | 5.12M | 71.00K | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 5.06M | 6.02M | 5.12M | 283.00K | n/a |
| Total Assets | 289.64M | 341.14M | 390.56M | 36.52M | 90.00K |
| Account Payables | 1.94M | 3.02M | 1.62M | 1.40M | 2.48M |
| Deferred Revenue | n/a | n/a | n/a | n/a | 201.00K |
| Short-Term Debt | 716.00K | 640.00K | 489.00K | n/a | 695.00K |
| Other Current Liabilities | 6.97M | 7.11M | 3.17M | 931.00K | 356.00K |
| Total Current Liabilities | 9.62M | 10.78M | 5.28M | 2.33M | 3.73M |
| Long-Term Debt | 2.33M | 6.10M | 6.29M | n/a | n/a |
| Other Long-Term Liabilities | n/a | -3.05M | -3.14M | 45.50M | 1K |
| Total Long-Term Liabilities | 2.33M | 3.05M | 3.14M | 45.50M | 1K |
| Total Liabilities | 11.96M | 13.83M | 8.43M | 47.83M | 3.73M |
| Total Debt | 3.05M | 3.69M | 3.63M | n/a | 695.00K |
| Common Stock | 6.00K | 6.00K | 6.00K | 1K | 1K |
| Retained Earnings | -177.63M | -110.76M | -47.46M | -11.92M | -3.64M |
| Comprehensive Income | 62.00K | -3.36M | -244.00K | 156.00K | n/a |
| Shareholders Equity | 277.69M | 327.31M | 382.13M | -11.31M | -3.64M |
| Total Investments | 260.60M | 303.89M | 85.50M | 33.71M | n/a |